COGNITIVE MODELS OF POSITIVE AND NEGATIVE SYMPTOMS OF SCHIZOPHRENIA AND IMPLICATIONS FOR TREATMENT

被引:1
|
作者
Batinic, Borjanka [1 ]
机构
[1] Univ Belgrade, Fac Philosophy, Clin Ctr Serbia, Dept Psychol,Clin Psychiat, Belgrade, Serbia
关键词
schizophrenia; cognitive behavioural models; implications for treatment; BEHAVIORAL THERAPY; DEFEATIST BELIEFS;
D O I
暂无
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
This article reviews cognitive models of positive and negative symptoms of schizophrenia, as well as basic principles of cognitive behavioural therapy (CBT) for hallucinations, delusions and negative symptoms. Cognitive models of schizophrenia posit that individuals' view of the self is influenced by a combination of genetic vulnerability, early childhood experience and environmental stressors later in the life, and that these factors determine how internal and external experiences are interpreted. Cognitive behavioural therapy for schizophrenia is based on the basic principles of CBT and establishes connection between thoughts, emotions and behaviour. Treatment focuses on the meaning the individual attributes to psychotic experience, his or her understanding of it and ways of coping with symptoms, and is intended to reduce the distress caused by psychotic experience and correct thoughts and assumptions that are incompatible with objective evidence. The latest contradictory data on the efficacy of CBT for schizophrenia point to the need to use protocols that are tailored to specific symptoms and subgroups of patients based on the stage of illness, level of neurocognitive impairment and severity of the disorder, and manual-based in order to ensure fidelity of implementation.
引用
收藏
页码:S181 / S184
页数:4
相关论文
共 50 条
  • [1] Treatment Implications of Situational Variability in Cognitive and Negative Symptoms of Schizophrenia
    Mote, Jasmine
    Grant, Paul M.
    Silverstein, Steven M.
    [J]. PSYCHIATRIC SERVICES, 2018, 69 (10) : 1095 - 1097
  • [2] THE USE OF RTMS AND TDCS IN THE TREATMENT OF THE POSITIVE, NEGATIVE AND COGNITIVE SYMPTOMS OF SCHIZOPHRENIA
    Fitzgerald, Paul B.
    Hoy, Kate
    Herring, Sally
    McQueen, Susan
    Karpinski, Amy
    Daskalakis, Zafiris Z.
    [J]. AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY, 2010, 44 : A16 - A16
  • [3] COGNITIVE-FUNCTIONING AND POSITIVE AND NEGATIVE SYMPTOMS IN SCHIZOPHRENIA
    ADDINGTON, J
    ADDINGTON, D
    MATICKATYNDALE, E
    [J]. SCHIZOPHRENIA RESEARCH, 1991, 5 (02) : 123 - 134
  • [4] COGNITIVE BEHAVIOR THERAPY FOR POSITIVE AND NEGATIVE SYMPTOMS OF SCHIZOPHRENIA
    Turkington, Douglas
    [J]. SCHIZOPHRENIA RESEARCH, 2012, 136 : S31 - S31
  • [5] Cognitive function in schizophrenia: Association with negative and positive symptoms
    Capleton, RA
    [J]. PSYCHOLOGICAL REPORTS, 1996, 78 (01) : 123 - 128
  • [6] Theories and models of negative symptoms in schizophrenia and clinical implications
    Chan, Raymond C. K.
    Wang, Ling-ling
    Lui, Simon S. Y.
    [J]. NATURE REVIEWS PSYCHOLOGY, 2022, 1 (08): : 454 - 467
  • [7] Theories and models of negative symptoms in schizophrenia and clinical implications
    Raymond C. K. Chan
    Ling-ling Wang
    Simon S. Y. Lui
    [J]. Nature Reviews Psychology, 2022, 1 : 454 - 467
  • [8] The relationship between positive and negative symptoms and cognitive disorders in schizophrenia
    Taghanaki, Rahimi Changiz
    [J]. INTERNATIONAL JOURNAL OF PSYCHOLOGY, 2008, 43 (3-4) : 804 - 804
  • [9] mGlu5-GABAB interplay in animal models of positive, negative and cognitive symptoms of schizophrenia
    Wieronska, Joanna M.
    Kleczek, Natalia
    Wozniak, Monika
    Gruca, Piotr
    Lason-Tyburkiewicz, Magdalena
    Papp, Mariusz
    Branski, Piotr
    Burnat, Grzegorz
    Pilc, Andrzej
    [J]. NEUROCHEMISTRY INTERNATIONAL, 2015, 88 : 97 - 109
  • [10] Phosphodiesterase 10A Inhibitor Activity in Preclinical Models of the Positive, Cognitive, and Negative Symptoms of Schizophrenia
    Grauer, Steven M.
    Pulito, Virginia L.
    Navarra, Rachel L.
    Kelly, Michele P.
    Kelley, Cody
    Graf, Radka
    Langen, Barbara
    Logue, Sheree
    Brennan, Julie
    Jiang, Lixin
    Charych, Erik
    Egerland, Ute
    Liu, Feng
    Marquis, Karen L.
    Malamas, Michael
    Hage, Thorsten
    Comery, Thomas A.
    Brandon, Nicholas J.
    [J]. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2009, 331 (02): : 574 - 590